| Patent application number | Description | Published |
| 20080283192 | METHOD AND APPARATUS FOR BONDING OPTICAL DISC SUBSTRATES TOGETHER, AND METHOD FOR SUPPLYING LIQUID MATERIAL - The object of the present invention is to significantly inhibit the formation of voids between substrates bonded together when a liquid adhesive is supplied onto an optical disc substrate or when the optical disc substrate is bonded to another optical disc substrate. Accordingly, the present invention discloses a method for bonding two optical disc substrates together which comprises the steps of joining the optical disc substrates together with an adhesive and curing the adhesive, wherein the adhesive is supplied onto the optical disc substrate by an electric field formed between the adhesive-supplying nozzle, for supplying the adhesive onto the optical disc substrate, and the optical disc substrate, and the two optical disc substrates are then joined together and subjected to spun by a spinning process. | 11-20-2008 |
| 20090022782 | Blood Retainable Device Exhibiting Selective Degradability in Tumor Tissue - A phospholipid derivative useful for the preparation of liposomes for efficient uptake of an antitumor agent or a gene intracellularly by a target tumor cell, which comprises a residue of an alcohol compound and a residue of a phospholipid, and comprising a peptide between the residue of an alcohol compound and the residue of a phospholipid, and wherein (a) the alcohol compound is an alcohol compound selected from poly(alkylene glycols) and the like, (b) the phospholipid is a phospholipid selected from phosphatidylethanolamines, phosphatidylcholines, phosphatidylserines and the like, and (c) the peptide is a peptide comprising a substrate peptide that can serve as a substrate of a matrix metalloproteinase, provided that one amino acid residue or an oligopeptide containing 2 to 8 amino acid residues may bind to one or both ends of the substrate peptide. | 01-22-2009 |
| 20090233366 | COMPOSITION FOR INTRODUCTION OF NUCLEIC ACID - Composition with weak cytotoxicity for introducing a nucleic acid, such as a short oligonucleotide or a gene, into a cell for expression of the gene in the cell. The composition includes a lipid and a compound represented by a formula (I): | 09-17-2009 |
| 20090239222 | COMPOSITION FOR NUCLEIC-ACID TRANSFECTION - To provide a nucleic-acid-transfecting composition which exhibits low cytotoxicity, which facilitates a nucleic acid transfection into cells, and which improves expression of the nucleic acid in the cells. | 09-24-2009 |
| 20100055684 | COMPOSITION FOR NUCLEIC ACID TRANSFECTION - The invention provides a nucleic-acid-transfecting composition which exhibits low cytotoxicity, which facilitates an effective nucleic acid transfection into a cell, and which improves expression of the nucleic acid in the cell. | 03-04-2010 |
| 20100098753 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR CARDIAC INFARCTION - The present invention relates to a novel preventive and/or therapeutic drug for myocardial infarction. | 04-22-2010 |
| 20100165161 | PHOTOELECTRIC CONVERSION APPARATUS - A photoelectric conversion apparatus includes: a first photoelectric conversion element generating a current by photoelectric conversion; a first current amplifying element for amplifying the current generated by the first photoelectric conversion element; a first detecting unit for detecting a reverse bias voltage value of the first photoelectric conversion element; and a first setting unit for setting the reverse bias voltage value of the first photoelectric conversion element at a first normal value based on a result of the detection by the first detecting unit, wherein the first normal value is larger than a depleting voltage of the first photoelectric conversion element. | 07-01-2010 |
| 20110215224 | PHOTOELECTRIC CONVERSION APPARATUS - An apparatus includes a first photoelectric conversion element configured to convert light into a current by a photoelectric conversion, a first current amplification unit configured to amplify the current, a first current monitoring unit configured to monitor the amplified current amplified and output a monitor signal, and a first bias voltage setting unit configured to gain the monitor signal by a factor less than 1 and apply a reverse bias voltage to the first photoelectric conversion element according to the gained monitor signal. | 09-08-2011 |